Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-05-29 Sale | 2025-06-03 6:34 pm | Checkpoint Therapeutics Inc. | CKPT | Fortress Biotech Inc. 10% Owner | 6,222,249 | $4.0548 | $25,230,221 | 0 (Direct) | View |
| 2025-04-02 Sale | 2025-04-03 7:27 pm | Checkpoint Therapeutics Inc. | CKPT | Oliviero James F III CEO, President and Director | 15,090 | $4.04 | $60,964 | 3,759,929 (Direct) | View |
| 2025-04-01 Sale | 2025-04-03 7:26 pm | Checkpoint Therapeutics Inc. | CKPT | GRAY WILLIAM GARRETT Chief Financial Officer | 12,322 | $4.05 | $49,904 | 1,446,322 (Direct) | View |
| 2025-02-07 Sale | 2025-02-11 9:00 pm | Checkpoint Therapeutics Inc. | CKPT | Oliviero James F III CEO, President and Director | 19,564 | $3.2727 | $64,027 | 3,775,019 (Direct) | View |
| 2025-02-06 Sale | 2025-02-07 8:30 pm | Checkpoint Therapeutics Inc. | CKPT | GRAY WILLIAM GARRETT Chief Financial Officer | 74,110 | $3.67 | $271,984 | 1,458,644 (Direct) | View |
| 2024-12-18 Sale | 2024-12-20 9:30 pm | Checkpoint Therapeutics Inc. | CKPT | Oliviero James F III CEO, President and Director | 822,397 | $3.7388 | $3,074,764 | 2,294,583 (Direct) | View |
| 2024-12-18 Sale | 2024-12-20 9:30 pm | Checkpoint Therapeutics Inc. | CKPT | GRAY WILLIAM GARRETT Chief Financial Officer | 268,432 | $4.01 | $1,076,412 | 1,032,754 (Direct) | View |
| 2024-06-26 Sale | 2024-06-28 8:01 pm | Checkpoint Therapeutics Inc. | CKPT | Oliviero James F III CEO, President and Director | 24,610 | $2.05 | $50,450 | 1,939,280 (Direct) | View |
| 2024-06-26 Sale | 2024-06-28 8:00 pm | Checkpoint Therapeutics Inc. | CKPT | GRAY WILLIAM GARRETT Chief Financial Officer | 13,038 | $2.06 | $26,858 | 672,186 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-05-28 Option Award | 2025-05-30 11:21 am | N/A N/A | Checkpoint Therapeutics Inc. | CKPT | WEISS MICHAEL S Director | 12,195 | $0 | 187,007 (Indirect) | View |
| 2025-05-30 Equity Swap | 2025-05-30 11:21 am | N/A N/A | Checkpoint Therapeutics Inc. | CKPT | WEISS MICHAEL S Director | 187,007 | $0 | 187,007 (Indirect) | View |
| 2025-05-29 Option Award | 2025-05-30 11:21 am | N/A N/A | Checkpoint Therapeutics Inc. | CKPT | WEISS MICHAEL S Director | 50,000 | $1.29 | 187,007 (Direct) | View |
| 2025-05-28 Option Award | 2025-05-30 11:20 am | N/A N/A | Checkpoint Therapeutics Inc. | CKPT | SALZMAN BARRY M Director | 12,195 | $0 | 0 (Direct) | View |
| 2025-05-30 Equity Swap | 2025-05-30 11:20 am | N/A N/A | Checkpoint Therapeutics Inc. | CKPT | SALZMAN BARRY M Director | 147,007 | $0 | 0 (Direct) | View |
| 2025-05-28 Option Award | 2025-05-30 11:19 am | N/A N/A | Checkpoint Therapeutics Inc. | CKPT | ROSENWALD LINDSAY A MD Director | 12,195 | $0 | 0 (Direct) | View |
| 2025-05-30 Equity Swap | 2025-05-30 11:19 am | N/A N/A | Checkpoint Therapeutics Inc. | CKPT | ROSENWALD LINDSAY A MD Director | 207,007 | $0 | 0 (Direct) | View |
| 2025-05-29 Option Award | 2025-05-30 11:19 am | N/A N/A | Checkpoint Therapeutics Inc. | CKPT | ROSENWALD LINDSAY A MD Director | 50,000 | $1.29 | 0 (Direct) | View |
| 2025-05-30 Equity Swap | 2025-05-30 11:18 am | N/A N/A | Checkpoint Therapeutics Inc. | CKPT | Oliviero James F III CEO, President and Director | 3,759,929 | $0 | 0 (Direct) | View |
| 2025-05-28 Option Award | 2025-05-30 11:17 am | N/A N/A | Checkpoint Therapeutics Inc. | CKPT | Herskowitz Neil Director | 12,195 | $0 | 0 (Direct) | View |
| 2025-05-30 Equity Swap | 2025-05-30 11:17 am | N/A N/A | Checkpoint Therapeutics Inc. | CKPT | Herskowitz Neil Director | 147,007 | $0 | 0 (Direct) | View |
| 2025-05-30 Equity Swap | 2025-05-30 11:16 am | N/A N/A | Checkpoint Therapeutics Inc. | CKPT | GRAY WILLIAM GARRETT Chief Financial Officer | 1,446,322 | $0 | 0 (Direct) | View |
| 2025-05-28 Option Award | 2025-05-30 11:15 am | N/A N/A | Checkpoint Therapeutics Inc. | CKPT | Bechon Christian Director | 12,195 | $0 | 0 (Direct) | View |
| 2025-05-30 Equity Swap | 2025-05-30 11:15 am | N/A N/A | Checkpoint Therapeutics Inc. | CKPT | Bechon Christian Director | 141,718 | $0 | 0 (Direct) | View |
| 2025-05-28 Option Award | 2025-05-30 11:14 am | N/A N/A | Checkpoint Therapeutics Inc. | CKPT | Amit Sharma Director | 12,195 | $0 | 0 (Direct) | View |
| 2025-05-30 Equity Swap | 2025-05-30 11:14 am | N/A N/A | Checkpoint Therapeutics Inc. | CKPT | Amit Sharma Director | 94,246 | $0 | 0 (Direct) | View |
| 2025-02-26 Option Award | 2025-02-27 4:25 pm | N/A N/A | Checkpoint Therapeutics Inc. | CKPT | Fortress Biotech Inc. 10% Owner | 18,500 | $0 | 6,222,249 (Direct) | View |
| 2025-01-30 Option Award | 2025-01-31 9:00 pm | N/A N/A | Checkpoint Therapeutics Inc. | CKPT | GRAY WILLIAM GARRETT Chief Financial Officer | 500,000 | $0 | 1,532,754 (Direct) | View |
| 2025-01-30 Option Award | 2025-01-31 9:00 pm | N/A N/A | Checkpoint Therapeutics Inc. | CKPT | Oliviero James F III CEO, President and Director | 1,500,000 | $0 | 3,794,583 (Direct) | View |
| 2024-12-31 Option Award | 2025-01-03 4:15 pm | N/A N/A | Checkpoint Therapeutics Inc. | CKPT | Fortress Biotech Inc. 10% Owner | 2,468,215 | $0 | 6,203,749 (Direct) | View |
| 2024-12-20 Gift | 2024-12-20 9:30 pm | N/A N/A | Checkpoint Therapeutics Inc. | CKPT | Oliviero James F III CEO, President and Director | 900,000 | $0 | 2,294,583 (Direct) | View |
| 2024-12-13 Option Award | 2024-12-17 9:33 pm | N/A N/A | Checkpoint Therapeutics Inc. | CKPT | WEISS MICHAEL S Director | 12,638 | $0 | 124,812 (Indirect) | View |
| 2024-12-13 Option Award | 2024-12-17 9:33 pm | N/A N/A | Checkpoint Therapeutics Inc. | CKPT | SALZMAN BARRY M Director | 17,638 | $0 | 134,812 (Direct) | View |
| 2024-12-13 Option Award | 2024-12-17 9:32 pm | N/A N/A | Checkpoint Therapeutics Inc. | CKPT | ROSENWALD LINDSAY A MD Director | 12,638 | $0 | 144,812 (Direct) | View |
| 2024-12-13 Option Award | 2024-12-17 9:32 pm | N/A N/A | Checkpoint Therapeutics Inc. | CKPT | Oliviero James F III CEO, President and Director | 2,077,700 | $0 | 4,016,980 (Direct) | View |
| 2024-12-13 Option Award | 2024-12-17 9:31 pm | N/A N/A | Checkpoint Therapeutics Inc. | CKPT | GRAY WILLIAM GARRETT Chief Financial Officer | 629,000 | $0 | 1,301,186 (Direct) | View |
| 2024-12-13 Option Award | 2024-12-17 9:30 pm | N/A N/A | Checkpoint Therapeutics Inc. | CKPT | Bechon Christian Director | 14,994 | $0 | 129,523 (Direct) | View |
| 2024-12-13 Option Award | 2024-12-17 9:30 pm | N/A N/A | Checkpoint Therapeutics Inc. | CKPT | Herskowitz Neil Director | 17,638 | $0 | 134,812 (Direct) | View |
| 2024-09-27 Option Award | 2024-10-01 4:15 pm | N/A N/A | Checkpoint Therapeutics Inc. | CKPT | Fortress Biotech Inc. 10% Owner | 146,341 | $0 | 3,735,534 (Direct) | View |
| 2024-06-26 Gift | 2024-06-28 8:01 pm | N/A N/A | Checkpoint Therapeutics Inc. | CKPT | Oliviero James F III CEO, President and Director | 37,890 | $0 | 1,939,280 (Direct) | View |
| 2024-05-24 Option Award | 2024-05-24 9:01 pm | N/A N/A | Checkpoint Therapeutics Inc. | CKPT | GRAY WILLIAM GARRETT Chief Financial Officer | 540,000 | $0 | 685,224 (Direct) | View |
| 2024-05-24 Option Award | 2024-05-24 9:00 pm | N/A N/A | Checkpoint Therapeutics Inc. | CKPT | Oliviero James F III CEO, President and Director | 1,660,000 | $0 | 2,001,780 (Direct) | View |
Ownership | 2024-05-24 4:05 pm | N/A N/A | Checkpoint Therapeutics Inc. | CKPT | Fortress Biotech Inc. 10% Owner | 0 | $0 | 4,289,193 (Direct) | View |
| 2024-05-14 Option Award | 2024-05-16 7:35 pm | N/A N/A | Checkpoint Therapeutics Inc. | CKPT | WEISS MICHAEL S Director | 82,051 | $0 | 112,174 (Indirect) | View |
| 2024-05-14 Option Award | 2024-05-16 7:34 pm | N/A N/A | Checkpoint Therapeutics Inc. | CKPT | Amit Sharma Director | 32,051 | $0 | 82,051 (Direct) | View |
| 2024-05-14 Option Award | 2024-05-16 7:33 pm | N/A N/A | Checkpoint Therapeutics Inc. | CKPT | SALZMAN BARRY M Director | 82,051 | $0 | 117,174 (Direct) | View |
| 2024-05-14 Option Award | 2024-05-16 7:32 pm | N/A N/A | Checkpoint Therapeutics Inc. | CKPT | ROSENWALD LINDSAY A MD Director | 82,051 | $0 | 132,174 (Direct) | View |
| 2024-05-14 Option Award | 2024-05-16 7:31 pm | N/A N/A | Checkpoint Therapeutics Inc. | CKPT | Herskowitz Neil Director | 82,051 | $0 | 117,174 (Direct) | View |
| 2024-05-14 Option Award | 2024-05-16 7:30 pm | N/A N/A | Checkpoint Therapeutics Inc. | CKPT | Bechon Christian Director | 82,051 | $0 | 114,529 (Direct) | View |
| 2024-03-20 Option Award | 2024-03-22 6:23 pm | N/A N/A | Checkpoint Therapeutics Inc. | CKPT | Fortress Biotech Inc. 10% Owner | 193,905 | $0 | 2,096,278 (Direct) | View |
Ownership | 2024-03-19 8:00 pm | N/A N/A | Checkpoint Therapeutics Inc. | CKPT | Amit Sharma Director | 0 | $0 | 50,000 (Direct) | View |